Skip to content
Immunexpress
  • Home
  • About Us
    • About Immunexpress
    • Executive Team
    • Board Of Directors
    • Careers
  • About Sepsis
    • The Sepsis Problem
    • Partnership with Sepsis Alliance
    • External Resources
  • About SeptiCyte®
    • SeptiCyte™ RAPID
    • Host Response
    • SeptiCyte™ LAB
  • Validation
    • Clinical Validation
    • Publications
    • Collaborators
  • Newsroom
  • Contact Us
Immunexpress
  • Home
  • About Us
    • About Immunexpress
    • Executive Team
    • Board Of Directors
    • Careers
  • About Sepsis
    • The Sepsis Problem
    • Partnership with Sepsis Alliance
    • External Resources
  • About SeptiCyte®
    • SeptiCyte™ RAPID
    • Host Response
    • SeptiCyte™ LAB
  • Validation
    • Clinical Validation
    • Publications
    • Collaborators
  • Newsroom
  • Contact Us

Archive for June 2021

Finding The Product- Market Fit, with Rollie Carlson Ph.D. CEO of Immunexpress

By Josephine Galatioto | June 23, 2021

Gurus, why should you have your engineers and researchers out in the field? How can they get a good product-market fit? What is the NOT INVENTED HERE factor and why should you avoid it? Dr. Carlson discusses this and more. Listen in as he provides further evidence that perfect should not be the enemy of…

Read More

About Us

Immunexpress is a privately-owned group of companies developing and commercializing revolutionary molecular diagnostics to aid clinicians in managing patients with, or suspected of, sepsis through analysis of molecular blood biomarkers from a patient’s immune system (the ‘host response’).

Additional Resources

Newsroom


Contact Us


Privacy policy


 

Tweets by @Immunexpress

© 2023 Immunexpress Inc. — all Rights Reserved.
425 Pontius Avenue North, Suite 470, Seattle, WA 98109 USA
+1 206.858.6436 – info@immunexpress.com

Scroll To Top